{"id":"W2795389053","doi":"10.1200/jco.2018.36.4_suppl.614","title":"Immunoscore to provide prognostic information in low- (T1-3N1) and high-risk (T4 or N2) subsets of stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial (NCCTG N0147; Alliance).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; FOLFOX; Internal medicine; Oncology; Stage (stratigraphy); Colorectal cancer; Oxaliplatin; Confidence interval; Hazard ratio; Proportional hazards model; Adjuvant; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002316153,0.000449124,0.0004919488,0.0004453273,0.0001527699,0.0006003152,0.000288952,0.000327862,0.001221924],"category_scores_gemma":[0.001958649,0.0001194199,0.0004686451,0.0003394699,0.0001820732,0.0003966092,0.0003949604,0.0005941956,0.0002542742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002804101,"about_ca_system_score_gemma":0.0003875496,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003275487,"about_ca_topic_score_gemma":0.0011798,"domain_scores_codex":[0.9996611,0.0001742409,0.00001944407,0.00004864497,0.00005965486,0.00003686023],"domain_scores_gemma":[0.9991679,0.0002518249,0.0002280038,0.00004636646,0.00008429996,0.0002215766],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.08416216,0.0009813624,0.8193882,0.0001715891,0.001142294,0.00009407293,0.0001135124,0.002116889,0.01331654,0.0001675436,0.002617865,0.07572809],"study_design_scores_gemma":[0.009757332,0.02355814,0.9297513,0.00005808621,0.001240827,0.0007751762,0.0001070153,0.02113566,0.009235814,0.0007537491,0.00358469,0.00004217451],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969658,0.0007302604,0.0007760294,0.0001351618,0.00002720758,0.0001824829,0.0003978977,0.00002643677,0.0007586355],"genre_scores_gemma":[0.9956717,0.0001077851,0.002181927,0.0001006884,0.0000440104,0.0001704094,0.001285862,0.000008928696,0.0004287203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002316153,"threshold_uncertainty_score":0.01224911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0481533432949303,"score_gpt":0.3961819419516077,"score_spread":0.3480285986566774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}